-
Mashup Score: 0Dexamethasone intravitreal implant in treatment-naïve diabetic macular oedema: findings from the prospective, multicentre, AUSSIEDEX study - 1 year(s) ago
Aim To evaluate the effectiveness of dexamethasone intravitreal implant 0.7 mg (DEX; Ozurdex) monotherapy in the patient subgroup of the AUSSIEDEX study with treatment-naïve diabetic macular oedema (DME). Methods The open-label, prospective, phase 4, real-world study included pseudophakic eyes and phakic eyes scheduled for cataract surgery that were treatment-naïve or non-responsive to…
Source: British Journal of OphthalmologyCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 1Page Not Found - 1 year(s) ago
Jump to Cookie Consent Skip to main content Contact Us Careers Get an Estimate Make a Gift Pay Your Bill …
Source: www.henryford.comCategories: General Medicine News, Latest HeadlinesTweet-
Results of a study presented by orthopaedic researchers Drs. Jonathan Shaw & Jason Davis are geared toward effectively managing pain & decreasing #opioid use after #TotalKneeReplacement surgery through adding oral #dexamethasone after outpatient surgery: https://t.co/Saq9tQo3Os https://t.co/G6gA7bikSa
-
-
Mashup Score: 1Ruxolitinib Plus Dexamethasone Improves Outcomes in HLH | ASH Clinical News | American Society of Hematology - 1 year(s) ago
Skip Nav Destination December 11, 2022 Ruxolitinib plus dexamethasone may become a first-line treatment for hemophagocytic lymphohistiocytosis (HLH), according to De Zhou, MD, of the First Affiliated Hospital, Zhejiang University…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
#ASH22 Combination therapy with #ruxolitinib plus #dexamethasone led to improved outcomes in #hemophagocytic #lymphohistiocytosis (#HLH) https://t.co/zxrsse7x5u
-
-
Mashup Score: 0Successful Adrenal Vein Sampling Using Dexamethasone Premedication in Patients With Iodine Contrast Media Allergy - 2 year(s) ago
An Endocrine Society Reading Room selection
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Objective: Evaluate the efficacy and safety of premedication with high-dose #dexamethasone to perform #adrenal vein sampling in patients with #iodine contrast media. #Endocrinology #ESReadingRoom @TheEndoSociety Read more: https://t.co/z6GymAcwXU https://t.co/TNoGA6BKrf
-
-
Mashup Score: 1High-Dose Dexamethasone Not Recommended for Dyspnea With Cancer - 2 year(s) ago
A randomized clinical trial sought to determine if high-dose dexamethasone would be an effective palliative treatment of dyspnea in patients with cancer.
Source: Oncology Nurse AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
High-dose #dexamethasone should not be used to treat #dyspnea in patients with cancer, according to the results of a randomized clinical trial. Study in @TheLancet Oncology. https://t.co/2njcLKGvVP #CancerCare
-
-
Mashup Score: 2A Tale of Two Doses Versus One (Dexamethasone for the Treatment of Mild to Moderate Pediatric Asthma) - First10EM - 2 year(s) ago
A critical appraisal of Martin 2022 – an RCT looking at 1 versus 2 doses of dexamethasone for the treatment of pediatric asthma
Source: First10EMCategories: Healthcare Professionals, Latest HeadlinesTweet-
A Tale of Two Doses Versus One (#Dexamethasone for the Treatment of Mild to Moderate #Pediatric #Asthma ) - @First10EM https://t.co/fer1PBXx1M
-
-
Mashup Score: 3
High-dose dexamethasone failed to improve shortness of breath compared with placebo among ambulatory patients with cancer, according to study results published in The Lancet Oncology.In addition, the researchers found increased treatment-associated adverse events associated with dexamethasone.
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#Dexamethasone FAILS to relieve shortness of breath among patients with cancer. https://t.co/vC4dwJJIz7 @MDAndersonNews #cancerresearch #symptommanagement #HemOnc #OncAlert #MedEd
-
-
Mashup Score: 2Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial - 2 year(s) ago
High-dose dexamethasone did not improve dyspnoea in patients with cancer more effectively than placebo and was associated with a higher frequency of adverse events. These data suggest that dexamethasone should not be routinely given to unselected patients with cancer for palliation of dyspnoea.
Source: The Lancet OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Also in the October issue: Effect of #dexamethasone on #dyspnoea in patients with #cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial https://t.co/ECNJx1LejV
-
-
Mashup Score: 1
The phase 2 MASTER trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone demonstrates the promise of minimal residual disease surveillance in newly diagnosed multiple myeloma with 0 or 1 high-risk cytogenetic abnormalities
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The phase 2 MASTER trial of #daratumumab, #carfilzomib, #lenalidomide, and #dexamethasone demonstrates the promise of minimal residual disease surveillance in newly diagnosed #multiplemyeloma with 0 or 1 high-risk cytogenetic abnormalities. #MMSM https://t.co/ouZU10aUlW
-
-
Mashup Score: 4Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial - 2 year(s) ago
High-dose dexamethasone did not improve dyspnoea in patients with cancer more effectively than placebo and was associated with a higher frequency of adverse events. These data suggest that dexamethasone should not be routinely given to unselected patients with cancer for palliation of dyspnoea.
Source: The Lancet OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New Research: Effect of #dexamethasone on #dyspnoea in patients with #cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial https://t.co/ECNJx1tDsn https://t.co/rNCGeEtCH8
-
New large study shows #Ozurdex monotherapy improved central subfield #retinal #thickness and visual acuity at 52 weeks in treatment-naïve diabetic macular edema. Read more here: https://t.co/vwRq0V5CGj #ophthalmology #retina #dexamethasone #diabetes #ozurdex https://t.co/UFNYSfCiLA